ES2159633T3 - Derivado de quinolona para tratamiento de la incontinencia urinaria. - Google Patents

Derivado de quinolona para tratamiento de la incontinencia urinaria.

Info

Publication number
ES2159633T3
ES2159633T3 ES95915256T ES95915256T ES2159633T3 ES 2159633 T3 ES2159633 T3 ES 2159633T3 ES 95915256 T ES95915256 T ES 95915256T ES 95915256 T ES95915256 T ES 95915256T ES 2159633 T3 ES2159633 T3 ES 2159633T3
Authority
ES
Spain
Prior art keywords
urinary incontinence
quinolona
derivative
treatment
inolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95915256T
Other languages
English (en)
Inventor
John Edward Warawa
Cyrus John Ohnmacht Jr
Diane Amy Trainor
James Michael Hulsizer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of ES2159633T3 publication Critical patent/ES2159633T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

(S)-(-)-4-(3-CIANOFENIL)-2-TRIFLUOROMETIL-4,6,7,8-TETRAHIDRO5(1H)QUINOLONA COMO ABRIDOR DEL CANAL DE POTASIO, UTIL PARA EL TRATAMIENTO DE INCONTINENCIA URINARIA, Y PROCESOS PARA SU PREPARACION
ES95915256T 1994-04-14 1995-04-13 Derivado de quinolona para tratamiento de la incontinencia urinaria. Expired - Lifetime ES2159633T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9407432A GB9407432D0 (en) 1994-04-14 1994-04-14 Heterocyclic derivative

Publications (1)

Publication Number Publication Date
ES2159633T3 true ES2159633T3 (es) 2001-10-16

Family

ID=10753541

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95915256T Expired - Lifetime ES2159633T3 (es) 1994-04-14 1995-04-13 Derivado de quinolona para tratamiento de la incontinencia urinaria.

Country Status (25)

Country Link
EP (1) EP0755382B1 (es)
JP (1) JP3782445B2 (es)
KR (1) KR100344885B1 (es)
CN (1) CN1058708C (es)
AT (1) ATE202089T1 (es)
AU (1) AU700773B2 (es)
BR (1) BR9507366A (es)
CA (1) CA2187525C (es)
CZ (1) CZ284652B6 (es)
DE (1) DE69521310T2 (es)
DK (1) DK0755382T3 (es)
ES (1) ES2159633T3 (es)
FI (2) FI114705B (es)
GB (1) GB9407432D0 (es)
GR (1) GR3036482T3 (es)
HK (1) HK1013999A1 (es)
HU (1) HU215387B (es)
MX (1) MX9603920A (es)
NO (1) NO307177B1 (es)
NZ (1) NZ283779A (es)
PL (2) PL183095B1 (es)
PT (1) PT755382E (es)
RU (1) RU2149870C1 (es)
SK (1) SK281124B6 (es)
WO (1) WO1995028388A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60036476T2 (de) * 1999-08-03 2008-06-12 Abbott Laboratories, Abbott Park Kalium kanalaktivatoren
EP1307429B1 (en) * 2000-08-02 2007-11-28 AstraZeneca AB Process for asymmetric synthesis of substituted 1,4-dihydropyridines
SE0200205D0 (sv) * 2002-01-24 2002-01-24 Astrazeneca Ab Method
CN102532015B (zh) * 2012-01-18 2013-10-23 云南大学 香豆素及其类似物的固相合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003148A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
GB9220570D0 (en) * 1991-10-21 1992-11-11 Ici Plc Therapeutic agent
GB9318935D0 (en) * 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives

Also Published As

Publication number Publication date
NO307177B1 (no) 2000-02-21
CA2187525C (en) 2006-01-24
DE69521310D1 (de) 2001-07-19
FI20040352A (fi) 2004-03-04
PL182031B1 (pl) 2001-10-31
KR100344885B1 (ko) 2002-11-30
GB9407432D0 (en) 1994-06-08
JPH09512254A (ja) 1997-12-09
EP0755382A1 (en) 1997-01-29
DK0755382T3 (da) 2001-09-10
PL183095B1 (pl) 2002-05-31
PL316790A1 (en) 1997-02-17
GR3036482T3 (en) 2001-11-30
CN1146202A (zh) 1997-03-26
SK281124B6 (sk) 2000-12-11
HUT76132A (en) 1997-06-30
BR9507366A (pt) 1997-09-23
FI114705B (fi) 2004-12-15
AU2219995A (en) 1995-11-10
MX9603920A (es) 1997-04-30
CZ298196A3 (en) 1997-02-12
RU2149870C1 (ru) 2000-05-27
CN1058708C (zh) 2000-11-22
NO964345D0 (no) 1996-10-11
DE69521310T2 (de) 2002-04-18
CZ284652B6 (cs) 1999-01-13
PT755382E (pt) 2001-11-30
EP0755382B1 (en) 2001-06-13
FI964019A (fi) 1996-10-07
CA2187525A1 (en) 1995-10-26
HU9602747D0 (en) 1996-11-28
FI964019A0 (fi) 1996-10-07
ATE202089T1 (de) 2001-06-15
NO964345L (no) 1996-12-11
WO1995028388A1 (en) 1995-10-26
HU215387B (hu) 1998-12-28
FI115630B (fi) 2005-06-15
AU700773B2 (en) 1999-01-14
SK131796A3 (en) 1997-05-07
HK1013999A1 (en) 1999-09-17
JP3782445B2 (ja) 2006-06-07
NZ283779A (en) 1998-02-26

Similar Documents

Publication Publication Date Title
PL318100A1 (en) 2-[(dihydro) pyrazolyl-3'-oxymethylene]anilides, method of obtaining them and their application
MXPA02001911A (es) Anticuerpos ctla-4 humanos y sus usos.
AU6549898A (en) Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina
EE04416B1 (et) a1L- agonistide kasutamine uriiniinkontinentsuse raviks
AUPM761094A0 (en) Treatment of hides
CA2339384A1 (en) Improved method for targeted topical treatment of disease
AU2002222180A1 (en) The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired pasticity
ES2159633T3 (es) Derivado de quinolona para tratamiento de la incontinencia urinaria.
EP0938898A3 (en) Treatment of pruritus
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
PT928183E (pt) Utilizacao de 1-hidroxilo-2-piridoneno para o tratamento da dermatite seborroica
HU9902097D0 (en) Method for treating glaucoma
ES2160893T3 (es) Procedimiento y compuestos intermedios para la preparacion de compuestos de fluoroolefinas plaguicidas.
AU4882897A (en) Disinfectant composition, particularly for the prevention of dermatitis induced by diapers, and method for its use
PT1032580E (pt) Processo para a n-desmetilacao de eritromicinas e seus derivados
MXPA03010633A (es) Metodo para trastornos de resequedad de ojos.
ZA974386B (en) New formulation for treatment of thromboembolism.
FR2720011B1 (fr) Composition pour le traitement des fruits et légumes par thermonébulisation, et procédé de traitement.
AU3247995A (en) Treatment of hides
FR2786099B1 (fr) Nouvelle application therapeutique de la 1,6-dimethyl-8beta- hydroxymethyl-10alpha-methoxyergoline
UA25165A (uk) Спосіб оперативhого лікуваhhя косоокості по в.і. ємчеhку
UA25164A (uk) Спосіб оперативhого лікуваhhя косоокості по в.і. ємчеhку
BR7500223U (pt) Condensador para tratamento termovácuo de transformador
GB9616332D0 (en) Methods, uses and devices for antimicrobial treatment of mammalian skin
SI0874843T1 (en) Substituted 4-(1h-benzimidazol-2-yl) 1,4)diazepanes useful for the treatment of allergic diseases

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 755382

Country of ref document: ES